Are previous viral infections important on the COVID-19 outcomes?

Código QR

Are previous viral infections important on the COVID-19 outcomes?

Guardado en:

Detalles Bibliográficos
Autores principales:	Jesus Torres-Flores, Nora A. Fierro
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/3fb30edbc9a941c788251d8524dc6059
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

The Features of Pathobiology and Clinical translation of Approved treatments for Coronavirus Disease 2019 (COVID-19)
por: Ali Fallah, et al.
Publicado: (2021)

Importance of family/social support and impact on adherence to diabetic therapy
por: Miller TA, et al.
Publicado: (2013)

Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
por: Lorber D
Publicado: (2014)

Treatment outcome and prognostic indices in patients with hyperglycemic emergencies
por: Ezeani IU, et al.
Publicado: (2013)

Partnering with diabetes educators to improve patient outcomes
por: Burke SD, et al.
Publicado: (2014)

Bariatric surgery outcomes: a single-center study in the United Arab Emirates
por: Abusnana S, et al.
Publicado: (2015)

Association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathy
por: Taylor-Stokes G, et al.
Publicado: (2011)

The effect of very low-calorie diets on renal and hepatic outcomes: a systematic review
por: Roll, et al.
Publicado: (2013)

Sex differences in type 2 diabetes: focus on disease course and outcomes
por: Arnetz L, et al.
Publicado: (2014)

Health outcomes in diabetics measured with Minnesota Community Measurement quality metrics
por: Takahashi PY, et al.
Publicado: (2014)

Clinical and behavioral factors associated with management outcome in hospitalized patients with diabetic foot ulcer
por: Yekta Z, et al.
Publicado: (2011)

Using the health action process approach to predict and improve health outcomes in individuals with type 2 diabetes mellitus
por: MacPhail M, et al.
Publicado: (2014)

Rag2 Deficiency Enhances Susceptibility to Systemic Mouse Adenovirus Type 1 Infection
por: Han-Kyul Lee, et al.
Publicado: (2021)

Correspondence on “prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection”
por: Rujittika Mungmunpuntipantip, et al.
Publicado: (2021)

Outcomes of Roux-en-Y gastric bypass surgery for severely obese patients with type 1 diabetes: a case series report
por: Carlos E Mendez, et al.
Publicado: (2010)

Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management
por: Nitzan O, et al.
Publicado: (2015)

Prevalence of diagnosed and undiagnosed diabetes mellitus in adults aged 19 years and older in Basrah, Iraq
por: Mansour AA, et al.
Publicado: (2014)

Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries
por: Ostenson CG, et al.
Publicado: (2013)

Diabetes mellitus and risk factors in human immunodeficiency virus-infected individuals at Jimma University Specialized Hospital, Southwest Ethiopia
por: Mohammed AE, et al.
Publicado: (2015)

Safety and tolerability of exenatide twice daily in patients with type 2 diabetes: integrated analysis of 5594 patients from 19 placebo-controlled and comparator-controlled clinical trials
por: Gurney K, et al.
Publicado: (2012)

Impact of Obesity and Its Associated Comorbid Conditions on COVID-19 Presentation
por: Mehanna O, et al.
Publicado: (2021)

Exenatide improves glucocorticoid-induced glucose intolerance in mice
por: Ruiying Zhao, et al.
Publicado: (2011)

Association of FTO and PPARG polymorphisms with obesity in Portuguese women
por: Ferreira Carlos F, et al.
Publicado: (2013)

Nutritional therapy for the management of diabetic gastroparesis: clinical review
por: Sadiya A
Publicado: (2012)

Current management strategies to target the increasing incidence of diabetes within Pakistan [Corrigendum]
por: Basit A, et al.
Publicado: (2019)

Is vitamin D status a determining factor for metabolic syndrome? A case-control study
por: Salekzamani S, et al.
Publicado: (2011)

Diet-induced metabolic hamster model of nonalcoholic fatty liver disease
por: Bhathena J, et al.
Publicado: (2011)

The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults
por: Da Costa LA, et al.
Publicado: (2012)

Prevalence of metabolic syndrome and its components based on a harmonious definition among adults in Morocco
por: El Brini O, et al.
Publicado: (2014)

Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity
por: Bruckbauer A, et al.
Publicado: (2013)

Effects of a leucine and pyridoxine-containing nutraceutical on body weight and composition in obese subjects
por: Zemel MB, et al.
Publicado: (2013)

Social support in type II diabetes care: a case of too little, too late
por: Sadasivan S, et al.
Publicado: (2012)

Emerging utility of once-weekly exenatide in patients with type 2 diabetes
por: Goud A, et al.
Publicado: (2015)

The economic impact of obesity in the United States
por: Ross A Hammond, et al.
Publicado: (2010)

The humanistic and economic burden associated with increasing body mass index in the EU5
por: Gupta S, et al.
Publicado: (2015)

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
por: Stanley Schwartz, et al.
Publicado: (2010)

Daily intake of rosehip extract decreases abdominal visceral fat in preobese subjects: a randomized, double-blind, placebo-controlled clinical trial
por: Nagatomo A, et al.
Publicado: (2015)

Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial
por: Srivanichakorn W, et al.
Publicado: (2015)

Saroglitazar for the treatment of hypertriglyceridemia in patients with type 2 diabetes: current evidence
por: Sosale A, et al.
Publicado: (2015)

Angiotensin receptor blocker telmisartan suppresses renal gluconeogenesis during starvation
por: Tojo A, et al.
Publicado: (2015)